Voacamine

Drug Profile

Voacamine

Alternative Names: Aspidos; MMH 18; MMH 8 for paediatric use - Millenia Hope; MMH Malarex; Vocamine

Latest Information Update: 17 Apr 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Millenia Hope
  • Class Antimalarials; Indole alkaloids
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Market Withdrawal Malaria

Most Recent Events

  • 13 Sep 2005 Launched for Malaria in Cameroon (PO)
  • 25 Aug 2005 Millenia Hope and Coca Cola have entered into an agreement to conduct a pilot programme of voacamine in Guinea Conakry, West Africa, for malaria
  • 25 Aug 2005 Millenia Hope has initiated enrolment of 200 patients in a pilot programme for malaria in Guinea Conakry, West Africa
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top